Anticoagulating CKD Patients With Atrial Fibrillation: Are We Asking the Right Questions?
Mayo Clin Proc
.
2023 May;98(5):653-654.
doi: 10.1016/j.mayocp.2023.03.010.
Author
Robert C Albright Jr
1
Affiliation
1
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN. Electronic address: albright.robert@mayo.edu.
PMID:
37137639
DOI:
10.1016/j.mayocp.2023.03.010
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Humans
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy
Substances
Anticoagulants